Alzheimer's Drug Discovery Foundation Investor
Provides funding to leading scientists who are conducting the most promising, innovative Alzheimer’s drug research worldwide.
Technology:
Cancer
Industry:
Investor
Headquarters:
New York, New York, United States
Founded Date:
1998-01-01
Employees Number:
11-50
Investor Type:
Venture Capital
Number Of Exits:
6
Investors Number:
25
Estimated Revenue:
$1M to $10M
Register and Claim Ownership